Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients

OBJECTIVES: This study aims to retrospectively assess C‐lectin‐like molecule 1 (CLL‐1) bimodal expression on CD34+ blasts in acute myeloid leukemia (AML) patients (total N = 306) and explore potential CLL‐1 bimodal associations with leukemia and patient‐specific characteristics. METHODS: Flow cytome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngai, Lok Lam, Ma, Connie Y., Maguire, Orla, Do, An D., Robert, Alberto, Logan, Aaron C., Griffiths, Elizabeth A., Nemeth, Michael J., Green, Cherie, Pourmohamad, Tony, van Kuijk, Bo J., Snel, Alexander N., Kwidama, Zinia W., Venniker‐Punt, Bianca, Cooper, James, Manz, Markus G., Gjertsen, Bjørn T., Smit, Linda, Ossenkoppele, Gert J., Janssen, Jeroen J. W. M., Cloos, Jacqueline, Sumiyoshi, Teiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457079/
https://www.ncbi.nlm.nih.gov/pubmed/34053123
http://dx.doi.org/10.1111/ejh.13672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457079/
https://www.ncbi.nlm.nih.gov/pubmed/34053123
http://dx.doi.org/10.1111/ejh.13672

Ejemplares similares